, Tracking Stock Market Picks
Enter Symbol:
Intermune, Inc. (ITMN) [hlAlert]

Strong Buy
up 471.09 %

Intermune, Inc. (ITMN) rated Strong Buy with price target $20 by Wall Street Access

Posted on: Thursday,  Dec 11, 2008  10:25 AM ET by Wall Street Access

Wall Street Access rated Strong Buy Intermune, Inc. (NASDAQ: ITMN) on 12/11/2008, when the stock price was $12.94.
Since then, Intermune, Inc. has gained 471.10% as of 09/26/2014's recent price of $73.90.
If you would have followed this Wall Street Access's recommendation on ITMN, you would have gained 471.09% of your investment in 2115 days.

InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.

We stay on top of the markets that you're interested in, watch for news and opportunities, and keep you informed of any trends or moves in the market that may affect your situation. We have many relationships which give us the ability to make our customers aware of potential opportunities and threats in the market. Our brokers have a depth of understanding rare in the brokerage industry, and an ability to handle your trades with finesse.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/11/2008 10:25 AM Buy
12.94 20.00
as of 12/24/2008
1 Week down  -6.22 %
1 Month up  32.32 %
3 Months   
1 YTD up  32.32 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy